Evidence map›Paper›PMID 26176954›Full record

ArticlePloS one2015

Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome.

Albert C Sek, Zhihui Xie, Kaoru Terai, Lauren M Long, Celeste Nelson, Arkadiusz Z Dudek, Kirk M Druey

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Arteriosclerosis, thrombosis, and vascular biology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Idiopathic systemic capillary leak syndrome (Clarkson disease).The Journal of allergy and clinical immunology · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Albert C SekNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Zhihui XieNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Kaoru TeraiDivision of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America.
Lauren M LongNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Celeste NelsonNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Arkadiusz Z DudekDivision of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America.
Kirk M DrueyNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
National Institutes of Health · USUniversity of Illinois Chicago · USNational Institute of Allergy and Infectious Diseases · US

Funding

Studies in the Pathogenesis of Systemic Capillary Leak SyndromeZIAAI001083 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DRUEY, KIRK M · 2009 to 2025
$11.5M
NIAID NIH HHS AI001083
6 · The paper itself

Abstract

Idiopathic systemic capillary leak syndrome (SCLS) is a rare and potentially fatal vascular disorder characterized by reversible bouts of hypotension and edema resulting from fluid and solute escape into soft tissues. Although spikes in permeability-inducing factors have been linked to acute SCLS flares, whether or not they act on an inherently dysfunctional endothelium is unknown. To assess the contribution of endothelial-intrinsic mechanisms in SCLS, we derived blood-outgrowth endothelial cells (BOEC) from patients and healthy controls and examined gene expression patterns. Ednra, encoding Endothelin receptor A (ETA)-the target of Endothelin 1 (ET-1)-was significantly increased in SCLS BOEC compared to healthy controls. Although vasoconstriction mediated by ET-1 through ETA activation on vascular smooth muscle cells has been well characterized, the expression and function of ETA receptors in endothelial cells (ECs) has not been described. To determine the role of ETA and its ligand ET-1 in SCLS, if any, we examined ET-1 levels in SCLS sera and functional effects of endothelial ETA expression. ETA overexpression in EAhy926 endothelioma cells led to ET-1-induced hyper-permeability through canonical mechanisms. Serum ET-1 levels were elevated in acute SCLS sera compared to remission and healthy control sera, suggesting a possible role for ET-1 and ETA in SCLS pathogenesis. However, although ET-1 alone did not induce hyper-permeability of patient-derived BOEC, an SCLS-related mediator (CXCL10) increased Edrna quantities in BOEC, suggesting a link between SCLS and endothelial ETA expression. These results demonstrate that ET-1 triggers classical mechanisms of vascular barrier dysfunction in ECs through ETA. Further studies of the ET-1-ETA axis in SCLS and in more common plasma leakage syndromes including sepsis and filovirus infection would advance our understanding of vascular integrity mechanisms and potentially uncover new treatment strategies.

Indexed as

Calcium SignalingCapillary Leak SyndromeCase-Control StudiesCell LineCell Membrane PermeabilityChemokine CXCL10Endothelial CellsEndothelin-1Endothelium, VascularFemaleGene Expression RegulationHumansInflammation MediatorsMaleMiddle AgedReceptor, Endothelin AChemokine CXCL10Endothelin-1Inflammation MediatorsReceptor, Endothelin A

Identifiers

PMID26176954
PMCPMC4503617
OpenAlexW880955915

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.